Skip to Content

Lincare rises, falls

Lincare rises, falls

CLEARWATER, Fla.--Analysts don't expect a private equity firm to follow in the Blackstone Group's footsteps and buy Apria Healthcare competitor Lincare. Lincare's stock was up 7.4% on June 19, the day news broke of Blackstone's acquisition of Apria, but it was down 4.7% the next day. At press time in early July, Lincare's stock was trading at $27.77 per share. Lincare's size and current stock price make a buyout unlikely, even though it has better profit margins and cash flow than Apria, analysts told CNN.

Comments

To comment on this post, please log in to your account or set up an account now.